Bill Cassidy

You have not my sympathy, my empathy. My understanding that this is something which can be devastating for someone.

It is going to be bad for this.

It is observational. It is not therapy.

I am a doctor. You are going to see my questions kind of reflect the technical aspect of this.

On the other hand, I think--it is maybe you, Dr. Madlock-Brown, who said we could do have the real world experience.

The Administration is pushing that if there are cures with NIH money, that the Federal Government can march in and dictate whether or not the intellectual property is taken if they don't like the price.

To what degree has this information that we have had for 2 years been translated by clinicians into different approaches, even if it is empiric?

You give a man a microphone and all of a sudden you can't control them.

You have not my sympathy, my empathy. My understanding that this is something which can be devastating for someone.

Congress has put significant funding toward this. We gave the Department of Health and Human Services $1 billion to study long COVID.

That gives us the ability to give not just money but oversight as to how these programs are being conducted.

I am a big proponent for obesity research.

I get that, yes--the more fiber, the apple juice is absorbed more rapidly than applesauce, which is more rapidly than an apple.

Let me interrupt you. I graduated from med school in 1983, and they have been talking about it since '83.

We know, we are told up here, but we often don't know what we know.

The PBMs allegedly make more money by costing you more money.

We cannot continue to pay the highest prices in the world for prescription drugs.

I am a big proponent for obesity research.

I get that, yes--the more fiber, the apple juice is absorbed more rapidly than applesauce, which is more rapidly than an apple.

The PBMs allegedly make more money by costing you more money.

We know, we are told up here, but we often don't know what we know.

Let me interrupt you. I graduated from med school in 1983, and they have been talking about it since '83.

This has been a subject of interest for me way before I got to the U.S. Senate.

We cannot continue to pay the highest prices in the world for prescription drugs.

I will also point out, though, that our colleagues, Senator Susan Collins and Jeanne Shaheen have led the Special Diabetes Program Reauthorization.